MIR2276

Across TCGA pan-cancer cohorts, MIR2276 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR2276 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MIR2276 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR2276 expression acts as an unfavorable survival marker, although some lineages such as KIRC and STAD show a favorable association.

READ, KIRC, and UCEC are the cancer types where MIR2276 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	III,IV	0.132	0.771	<.001	69	view →
KIRC	OS	Tertile	All	0.934	0.862	.011	63	view →
UCEC	DFS	Tertile	II,III,IV	0.595	0.834	<.001	60	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
THYM	OS	Tertile	All	0.534	0.977	<.001	39	view →
KIRP	OS	Tertile	IV	0.111	0.503	<.001	39	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
BLCA	OS	Tertile	IV	0.226	0.602	.021	36	view →
ACC	DFS	Tertile	All	0.114	0.772	<.001	27	view →
LUSC	OS	Tertile	II,III,IV	0.311	0.627	.009	24	view →
ESCA	DFS	Quartile	II,III,IV	0.122	0.753	.016	20	view →
CHOL	OS	Tertile	III,IV	0.162	0.915	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR2276–READ (DFS)

Open the READ breakdown →